|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-6-16
|
|
pubmed:abstractText |
The majority of patients with early-stage breast cancer are treated with breast-conserving therapy (BCT). Several clinical risk factors are associated with local recurrence (LR) after BCT but are unable to explain all instances of LR after BCT. Here, gene expression microarrays are used to identify novel risk factors for LR after BCT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4181-90
|
|
pubmed:dateRevised |
2011-4-21
|
|
pubmed:meshHeading |
pubmed-meshheading:19470741-Adult,
pubmed-meshheading:19470741-Age Factors,
pubmed-meshheading:19470741-Breast Neoplasms,
pubmed-meshheading:19470741-Case-Control Studies,
pubmed-meshheading:19470741-Combined Modality Therapy,
pubmed-meshheading:19470741-Estrogen Receptor alpha,
pubmed-meshheading:19470741-Female,
pubmed-meshheading:19470741-Gene Expression Profiling,
pubmed-meshheading:19470741-Humans,
pubmed-meshheading:19470741-Kaplan-Meier Estimate,
pubmed-meshheading:19470741-Mastectomy, Segmental,
pubmed-meshheading:19470741-Neoplasm Recurrence, Local,
pubmed-meshheading:19470741-Receptor, erbB-2,
pubmed-meshheading:19470741-Risk Factors
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients.
|
|
pubmed:affiliation |
Division of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
